Skip to main content
OpenTrials

Clinical trial condition

Bone Diseases

Explore clinical trials studying Bone Diseases. Study availability and eligibility vary by location and protocol.

5,840 public trials 802 recruiting studies
Refine in advanced search Browse all conditions

Bone Diseases trial results

Completed

A Post-Marketing Study of the Immunogenicity of Somatropin (Ribosomal Deoxyribo Nucleic Acid [rDNA] Origin) Injection (Nutropin AQ®) in Children With Growth Hormone Deficiency

NCT02311894

Conditions
Bone Diseases, Bone Diseases, Developmental, Bone Diseases, Endocrine, +11 more
Locations
  • Arkansas Children's Hospital Research Institute Little Rock, Arkansas, United States
  • Children'S Hospital of Orange County Orange, California, United States
  • Center of Excellence in Diabetes & Endocrinology Sacramento, California, United States
  • San Diego Medical Group; Pediatric Endocrinology San Diego, California, United States
View all 33 locations
View Trial Details
Completed

A Study of Ixekizumab in Participants With Active Psoriatic Arthritis

NCT01695239

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +11 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Huntsville, Alabama, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tuscaloosa, Alabama, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Little Rock, Arkansas, United States
View all 116 locations
View Trial Details
Completed

16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients

NCT02008916

Conditions
Ankylosis, Arthritis, Axial Spondyloarthritis, +8 more
Locations
  • Novartis Investigative Site Mobile, Alabama, United States
  • Novartis Investigative Site Mesa, Arizona, United States
  • Novartis Investigative Site Peoria, Arizona, United States
  • Novartis Investigative Site Upland, California, United States
View all 57 locations
View Trial Details
Completed

Non Interventional Post Marketing Programme in Acromegaly

NCT00747500

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations
  • Aberdeen Royal Infirmary Aberdeen, United Kingdom
  • Barnsley General Hospital Barnsley, United Kingdom
  • University Hospital Coventry & Warwickshire Coventry, United Kingdom
  • Leeds General Infirmary Leeds, United Kingdom
View Trial Details
Completed

Adalimumab in Axial Spondyloarthritis (ASIM) - MRI and Biomarkers in Patients With Spondyloarthritis

NCT01029847

Conditions
Arthritis, Bone Diseases, Joint Diseases, +5 more
Locations
  • Dep. of medicine, Herlev Hospital Copenhagen, Denmark
  • Dep. of Radiology, Herlev Hospital Copenhagen, Denmark
  • Dep. of Rheumatology, Frederiksberg and Bispebjerg Hospitals Copenhagen, Denmark
  • Dep. of Rheumatology, Gentofte Hospital Copenhagen, Denmark
View Trial Details

Related conditions